Prognostic significance of YY1 protein expression and mRNA levels by bioinformatics analysis in human cancers: A therapeutic target

Pharmacology and Therapeutics

Volumn 150, Issue , 2015, Pages 149-168

  Bonavida, Benjamin ^a   Kaufhold, Samantha ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bioinformatics; Cancer; Prognosis; Resistance; Therapy; YY1

Indexed keywords

BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR YY1;

ANIMAL; AUTOPHAGY; BIOLOGY; DRUG RESISTANCE; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PATHOLOGY;

ANIMALS; AUTOPHAGY; COMPUTATIONAL BIOLOGY; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MOLECULAR TARGETED THERAPY; NEOPLASMS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; YY1 TRANSCRIPTION FACTOR;

EID: 84939946313     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2015.01.011     Document Type: Review

References (145)

1. B. Affar el, F. Gay, Y. Shi, H. Liu, M. Huarte, and S. Wu Essential dosage-dependent functions of the transcription factor yin yang 1 in late embryonic development and cell cycle progression Mol Cell Biol 26 2006 3565 3581
2. L. Agnelli, L. Mosca, S. Fabris, M. Lionetti, A. Andronache, and I. Kwee A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: An integrated genomics approach reveals a wide gene dosage effect Genes Chromosomes Cancer 48 2009 603 614
3. I. Akalay, B. Janji, M. Hasmim, M.Z. Noman, F. André, and P. De Cremoux Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis Cancer Res 73 2013 2418 2427
4. A. Allouche, G. Nolens, A. Tancredi, L. Delacroix, J. Mardaga, and V. Fridman The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors Breast Cancer Res 10 2008 R9
5. M. Atchison, A. Basu, K. Zaprazna, and M. Papasani Mechanisms of Yin Yang 1 in oncogenesis: The importance of indirect effects Crit Rev Oncog 16 2011 143 161
6. M. Bain, and J. Sinclair Targeted inhibition of the transcription factor YY1 in an embryonal carcinoma cell line results in retarded cell growth, elevated levels of p53 but no increase in apoptotic cell death Eur J Cell Biol 84 2005 543 553
7. S. Baritaki, A.M. Chatzinikola, A.F. Vakis, N. Soulitzis, D.A. Karabetsos, and I. Neonakis YY1 Over-expression in human brain gliomas and meningiomas correlates with TGF-beta1, IGF-1 and FGF-2 mRNA levels Cancer Invest 27 2009 184 192
8. S. Baritaki, A. Katsman, D. Chatterjee, K.C. Yeung, D.A. Spandidos, and B. Bonavida Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 upregulation J Immunol 179 2007 5441 5453
9. S. Baritaki, L. Militello, G. Malaponte, D.A. Spandidos, M. Salcedo, and B. Bonavida The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: Role in sensitization to TRAIL apoptosis Int J Oncol 38 2011 1683 1694
10. S. Baritaki, K. Yeung, M. Palladino, J. Berenson, and B. Bonavida Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization Cancer Res 69 2009 8376 8385
11. J. Barretina, B.S. Taylor, S. Banerji, A.H. Ramos, M. Lagos-Quintana, and P.L. Decarolis Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy Nat Genet 42 2010 715 721
12. K. Basso, A.A. Margolin, G. Stolovitzky, U. Klein, R. Dalla-Favera, and A. Califano Reverse engineering of regulatory networks in human B cells Nat Genet 37 2005 382 390
13. D.Y. Begon, L. Delacroix, D. Vernimmen, P. Jackers, and R. Winkler Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells J Biol Chem 280 2005 24428 24434
14. A. Berchuck, E.S. Iversen, J.M. Lancaster, J. Pittman, J. Luo, and P. Lee Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers Clin Cancer Res 11 2005 3686 3696
15. V. Bevelacqua, Y. Bevelacqua, S. Candido, E. Skarmoutsou, A. Amoroso, and C. Guarneri Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma Oncotarget 3 2012 882 892
16. A. Bhattacharjee, W.G. Richards, J. Staunton, C. Li, S. Monti, and P. Vasa Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses Proc Natl Acad Sci U S A 98 2001 13790 13795
17. B. Bonavida, and S. Baritaki Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry Nitric Oxide 24 2011 1 7
18. B. Bonavida, and S. Baritaki The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-kB/Snail/YY1/RKIP/PTEN circuitry Crit Rev Oncog 16 2011 211 226
19. T. Bonome, D.A. Levine, J. Shih, M. Randonovich, C.A. Pise-Masison, and F. Bogomolniy A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer Cancer Res 68 2008 5478 5486
20. A.P. Bracken, D. Pasini, M. Capra, E. Prosperini, E. Colli, and K. Helin EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer EMBO J 22 2003 5323 5335
21. T.A. Brooks, S. Kendrick, and L. Hurley Making sense of G-quadruplex and i-motif functions in oncogene promoters FEBS J 277 2010 3459 3469
22. Y. Cao, Z. Gao, L. Li, X. Jiang, A. Shan, and J. Cai Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1 Nat Commun 4 2013 2810
23. G. Caretti, M. Di Padova, B. Micales, G.E. Lyons, and V. Sartorelli The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation Genes Dev 18 2004 2627 2638
24. G. Castellano, E. Torrisi, G. Ligresti, F. Nicoletti, G. Malaponte, and S. Traval Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression Cell Cycle 9 2010 557 563
25. X. Chen, S.T. Cheung, S. So, S.T. Fan, C. Barry, and J. Higgins Gene expression patterns in human liver cancers Mol Biol Cell 13 2002 1929 1939
26. Y. Chen, R. Jacamo, M. Konopleva, R. Garzon, C. Croce, and M. Andreeff CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia J Clin Invest 123 2013 2395 2407
27. D. Chinnappan, D. Xiao, A. Ratnasari, C. Andry, T.C. King, and H.C. Weber Transcription factor YY1 expression in human gastrointestinal cancer cells Int J Oncol 34 2009 1417 1423
28. E. Coustan-Smith, G. Song, C. Clark, L. Key, P. Liu, and M. Mehrpooya New markers for minimal residual disease detection in acute lymphoblastic leukemia Blood 117 2011 6267 6276
29. F. Crea, E.M. Hurt, and W.L. Farrar Clinical significance of Polycomb gene expression in brain tumors Mol Cancer 9 2010 265
30. Critical Reviews in Oncogenesis Special issue: Yin yang 1 and oncogenesis 16 2011 141 267
31. J. Cui, Y. Chen, W.C. Chou, L. Sun, L. Chen, and J. Suo An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer Nucleic Acids Res 39 2011 1197 1207
32. C. Curtis, S.P. Shah, S.F. Chin, G. Turashvili, O.M. Rueda, and M.J. Dunning The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups Nature 486 2012 346 352
33. F. de Nigris, C. Botti, A. de Chiara, R. Rossiello, G. Apice, and F. Fazioli Expression of transcription factor Yin Yang 1 in human osteosarcomas Eur J Cancer 42 2006 2420 2424
34. F. de Nigris, V. Crudele, A. Giovane, A. Casamassimi, A. Giordano, and H.J. Garban CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy Proc Natl Acad Sci U S A 107 2010 14484 14489
35. F. de Nigris, R. Rossiello, C. Schiano, C. Arra, S. Williams-Ignarro, and A. Barbieri Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis Cancer Res 68 2008 1797 1808
36. F. de Nigris, L. Zanella, F. Cacciatore, A. De Chiara, F. Fazioli, and G. Chiappetta YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma BMC Cancer 11 2011 472
37. K. DeClerck, and R.C. Elble The role of hypoxia and acidosis in promoting metastasis and resistance to chemotherapy Front Biosci 15 2010 213 225
38. S.M. Dehm, and D.J. Tindall Regulation of androgen receptor signaling in prostate cancer Expert Rev Anticancer Ther 5 2005 63 74
39. Z. Deng, P. Cao, M.M. Wan, and G. Sui Yin Yang 1: A multifaceted protein beyond a transcription factor Transcription 1 2010 81 84
40. Z. Deng, M. Wan, P. Cao, A. Rao, S.D. Cramer, and G. Sui Yin Yang 1 regulates the transcriptional activity of androgen receptor Oncogene 28 2009 3746 3757
41. Z. Deng, M. Wan, and G. Sui PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger Mol Cell Biol 27 2007 3780 3792
42. J. Eddy, and N. Maizels Gene function correlates with potential for G4 DNA formation in the human genome Nucleic Acids Res 34 2006 3887 3896
43. S.J. Erkeland, M. Valkhof, C. Heijmans-Antonissen, R. Delwel, P.J. Valk, and M.H. Hermans The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation Blood 101 2003 1111 1117
44. L. Feng, Y. Ma, J. Sun, Q. Shen, L. Liu, and H. Lu YY1-MIR372-SQSTM1 regulatory axis in autophagy Autophagy 10 2014 1442 1453
45. J.R. Flanagan, K.G. Becker, D.L. Ennist, S.L. Gleason, P.H. Driggers, and B.Z. Levi Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus Mol Cell Biol 12 1992 38 44
46. N.R. Galloway, C.J. Diaz Osterman, K. Reiber, J.M. Jutzy, F. Li, and G. Sui Yin Yang 1 regulates the transcriptional repression of Survivin Biochem Biophys Res Commun 445 2014 208 213
47. H. Garban, and B. Bonavida Nitric oxide inhibits the transcription receptor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the upregulation of Fas gene expression in human tumor cells J Immunol 167 2001 75 81
48. S. Gluck, J.S. Ross, M. Royce, E.F. McKenna Jr., C.M. Perou, and E. Avisar TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine +/- trastuzumab Breast Cancer Res Treat 132 2012 781 791
49. S. Gordon, G. Akopyan, H. Garban, and B. Bonavida Transcription factor YY1: Structure, function, and therapeutic implications in cancer biology Oncogene 25 2006 1125 1142
50. E. Gronroos, A.A. Terentiev, T. Punga, and J. Ericsson YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress Proc Natl Acad Sci U S A 101 2004 12165 12170
51. L. Grubach, C. Juhl-Christensen, A. Rethmeier, L.H. Olesen, A. Aggerholm, and P. Hokland Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia Eur J Haematol 81 2008 112 122
52. T. Haferlach, A. Kohlmann, L. Wieczorek, G. Basso, G.T. Kronnie, and M.C. Bene Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: Report from the International Microarray Innovations in Leukemia Study Group J Clin Oncol 28 2010 2529 2537
53. N. Hariharan, D.E. Kelley, and R.P. Perry Delta, a transcription factor that binds to downstream elements in several polymerase II promoters, is a functionally versatile zinc finger protein Proc Natl Acad Sci U S A 88 1991 9799 9803
54. G. He, Q. Wang, Y. Zhou, X. Wu, L. Wang, and N. Duru YY1 is a novel potential therapeutic target for the treatment of HPV infection-induced cervical cancer by arsenic trioxide Int J Gynecol Cancer 21 2011 1097 1104
55. C.A. Heinlein, and C. Chang Androgen receptor in prostate cancer Endocr Rev 25 2004 276 308
56. J. Hou, J. Aerts, B. den Hamer, W. van Ijcken, M. den Bakker, and P. Riegman Gene expression-based classification of non-small cell lung carcinomas and survival prediction PLoS One 5 2010 e10312
57. H.B. Houbaviy, A. Usheva, T. Shenk, and S.K. Burley Cocrystal structure of YY1 bound to the adenoassociated virus P5 initiator Proc Natl Acad Sci U S A 93 1996 13577 13582
58. F.S. Hsieh, N.T. Chen, Y.L. Yao, S.Y. Wang, J.J. Chen, and C.C. Lai The transcriptional repression activity of STAF65γ is facilitated by promoter tethering and nuclear import of class IIa histone deacetylases Biochim Biophys Acta 1839 2014 579 591
59. W. Huang, P.J. Smaldino, Q. Zhang, L.D. Miller, P. Cao, and K. Stadelman Yin Yang 1 contains G-quadruplex structures in its promoter and 5′-UTR and its expression is modulated by G4 resolvase 1 Nucleic Acids Res 40 2012 1033 1049
60. S. Huerta-Yepez, S. Baritaki, G. Baay-Guzman, M.A. Hernandez-Luna, A. Hernandez-Cueto, and M.I. Vega Contribution of either YY1 or Bcl(XL)-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and Bcl(XL) are overexpressed in prostate cancer Nitric Oxide 29C 2013 17 24
61. S. Huerta-Yepez, H. Liu, S. Baritaki, M. Del Lourdes Cebrera-Munoz, C. Rivera-Pazos, and A. Maldonado-Valenzuela Overexpression of Yin Yang 1 in bone marrow-derived human multiple myeloma and its clinical significance Int J Oncol 45 2014 1184 1192
62. S. Huerta-Yepez, M. Vega, S.E. Escoto-Chavez, B. Murdock, T. Sakai, and S. Baritaki Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1 Nitric Oxide 20 2009 39 52
63. S. Huerta-Yepez, M. Vega, H. Garban, and B. Bonavida Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis Clin Immunol 120 2006 297 309
64. S. Huerta-Yepez, M. Vega, A. Jazirehi, H. Garban, F. Hongo, and G. Cheng Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression Oncogene 23 2004 4993 5003
65. A. Jain, A. Lam, I. Vivanco, M.F. Carey, and R.E. Reiter Identification of an androgen-dependent enhancer within the prostate stem cell antigen gene Mol Endocrinol 16 2002 2323 2337
66. A.R. Jazirehi, M.I. Vega, D. Chatterjee, L. Goodglick, and B. Bonavida Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab Cancer Res 64 2004 7117 7126
67. B. Joshi, S. Rastogi, M. Morris, L.M. Carastro, C. DeCook, and E. Seto Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites Biochem J 401 2007 155 166
68. W. Kang, J.H. Tong, A.W. Chan, J. Zhao, Y. Dong, and S. Wang Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma J Transl Med 12 2014 80
69. V. Kashyap, and B. Bonavida Role of YY1 in the pathogenesis of prostate cancer and correlation with bioinformatic data sets of gene expression Genes Cancer 5 2014 71 83
70. J.D. Kim, C. Faulk, and J. Kim Retroposition and evolution of the DNA-binding motifs of YY1, YY2, and REX1 Nucleic Acids Res 35 2007 3442 3452
71. J.D. Kim, S. Yu, and J. Kim YY1 is autoregulated through its own DNA-binding sites BMC Mol Biol 10 2009 85
72. M.H. Lee, T. Lahusen, R.H. Wang, C. Xiao, X. Xu, and Y.S. Hwang Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation Oncogene 31 2012 116 127
73. J.S. Lee, S.H. Leem, S.Y. Lee, S.C. Kim, E.S. Park, and S.B. Kim Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors J Clin Oncol 28 2010 2660 2667
74. Y. Li, F. Wang, J. Xu, F. Ye, Y. Shen, and J. Zhou Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29 J Pathol 224 2011 484 495
75. H. Liu, and Y. Shi Yin Yang 1 S. Iuchi, N. Kuldell, Zinc finger proteins: From atomic contact to cellular function 2005 Springer New York
76. J. Luo, X. Zhou, X. Ge, P. Liu, J. Cao, and X. Lu Upregulation of Ying Yang 1 (YY1) suppresses esophageal squamous cell carcinoma development through heme oxygenase-1 Cancer Sci 104 2013 1544 1551
77. M.L. Moore, M.A. Teitell, Y. Kim, T. Watabe, R.E. Reiter, and O.N. Witte Deletion of PSCA increases metastasis of TRAMP-induced prostate tumors without altering primary tumor formation Prostate 68 2008 139 151
78. N.H. Myong Loss of E-cadherin and Acquisition of Vimentin in Epithelial-Mesenchymal Transition are Noble Indicators of Uterine Cervix Cancer Progression Korean J Pathol 46 2012 341 348
79. K. Naidoo, and R.J. Byers YY1 as a therapeutic target in cancer Forum Immunopathol Dis Ther 2010 2010 51 64
80. K. Naidoo, V. Clay, J.A. Hoyland, R. Swindell, K. Linton, and T. Illidge YY1 expression predicts favourable outcome in follicular lymphoma J Clin Pathol 64 2011 125 129
81. N. Nguyen, X. Zhang, N. Olashaw, and E. Seto Molecular cloning and functional characterization of the transcription factor YY2 J Biol Chem 279 2004 25927 25934
82. S. Nicholson, H. Whitehouse, K. Naidoo, and R.J. Byers Yin Yang 1 in human cancer Crit Rev Oncog 16 2011 245 260
83. M.J. O'Connor, S.H. Tan, C.H. Tan, and H.U. Bernard YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity J Virol 70 1996 6529 6539
84. H. Okayama, T. Kohno, Y. Ishii, Y. Shimada, K. Shiraishi, and R. Iwakawa Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas Cancer Res 72 2012 100 111
85. M.B. Palmer, P. Majumder, J.C. Cooper, H. Yoon, P.A. Wade, and J.M. Boss Yin yang 1 regulates the expression of snail through a distal enhancer Mol Cancer Res 7 2009 221 229
86. K. Park, and M.L. Atchison Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3′ enhancer and the immunoglobulin heavy-chain mu E1 site Proc Natl Acad Sci U S A 88 1991 9804 9808
87. B.L. Petrella, and C.E. Brinckerhoff PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma Cancer Biol Ther 8 2009 1389 1401
88. C. Pilarsky, M. Wenzig, T. Specht, H.D. Saeger, and R. Grutzmann Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data Neoplasia 6 2004 744 750
89. V. Potluri, S.K. Noothi, S.D. Vallabhapurapu, S.O. Yoon, J.J. Driscoll, and C.H. Lawrie Transcriptional repression of Bim by a novel YY1-RelA complex is essential for the survival and growth of Multiple Myeloma PLoS One 8 2013 e66121
90. D.G. Powe, G. Akhtar, H.O. Habashy, T. Abdel-Fatah, E.A. Rakha, and A.R. Green Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification Breast Cancer Res 11 2009 R90
91. S. Raguz, and E. Yague Resistance to chemotherapy: New treatments and novel insights into an old problem Br J Cancer 99 2008 387 391
92. C. Ramkumar, H. Cui, Y. Kong, S.N. Jones, R.M. Gerstein, and H. Zhang Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1 Nat Commun 4 2013 2598
93. J.C. Reed Dysregulation of apoptosis in cancer J Clin Oncol 17 1999 2941 2953
94. R.E. Reiter, Z. Gu, T. Watabe, G. Thomas, K. Szigeti, and E. Davis Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer Proc Natl Acad Sci U S A 95 1998 1735 1740
95. G. Ren, G. Zhang, Z. Dong, Z. Liu, L. Li, and Y. Feng Recruitment of HDAC4 by transcription factor YY1 represses HOXB13 to affect cell growth in AR-negative prostate cancers Int J Biochem Cell Biol 41 2009 1094 1101
96. R. Rizkallah, and M.M. Hurt Regulation of the transcription factor YY1 in mitosis through phosphorylation of its DNA-binding domain Mol Biol Cell 20 2009 4766 4776
97. S. Roessler, H.L. Jia, A. Budhu, M. Forgues, Q.H. Ye, and J.S. Lee A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients Cancer Res 70 2010 10202 10212
98. A. Rosenwald, G. Wright, W.C. Chan, J.M. Connors, E. Campo, and R.I. Fisher The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma N Engl J Med 346 2002 1937 1947
99. S. Ross, S.D. Spencer, I. Holcomb, C. Tan, J. Hongo, and B. Devaux Prostate stem cell antigen as therapy target: Tissue expression and in vivo efficacy of an immunoconjugate Cancer Res 62 2002 2546 2553
100. S. Ross, S.D. Spencer, L.A. Lasky, and H. Koeppen Selective expression of murine prostate stem cell antigen in fetal and adult tissues and the transgenic adenocarcinoma of the mouse prostate model of prostate carcinogenesis Am J Pathol 158 2001 809 816
101. M. Rylski, R. Amborska, K. Zybura, B. Mioduszewska, P. Michaluk, and J. Jaworski Yin Yang 1 is a critical repressor of matrix metalloproteinase-9 expression in brain neurons J Biol Chem 283 2008 35140 35153
102. E. Sakhinia, C. Glennie, J.A. Hoyland, L.P. Menasce, G. Brady, and C. Miller Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling Blood 109 2007 3922 3928
103. M. Sanchez-Carbayo, N.D. Socci, J. Lozano, F. Saint, and C. Cordon-Cardo Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays J Clin Oncol 24 2006 778 789
104. H.E. Sandison, S. Usher, E.G. Karimiani, G. Ashton, L.P. Menasce, and J.A. Radford PLK1 and YY1 interaction in follicular lymphoma is associated with unfavourable outcome J Clin Pathol 66 2013 764 767
105. WAF1/Cip1-Cdk4-cyclin D1 assembly Circ Res 101 2007 146 155
106. J. Schug, W.P. Schuller, C. Kappen, J.M. Salbaum, M. Bucan, and C.J. Stoeckert Jr. Promoter features related to tissue specificity as measured by Shannon entropy Genome Biol 6 2005 R33
107. D. Seligson, S. Horvath, S. Huerta-Yepez, S. Hanna, H. Garban, and A. Roberts Expression of transcription factor Yin Yang 1 in prostate cancer Int J Oncol 27 2005 131 141
108. E. Seto, Y. Shi, and T. Shenk YY1 is an initiator sequencebinding protein that directs and activates transcription in vitro Nature 354 1991 241 245
109. M.A. Shah, and G.K. Schwartz Cell cycle-mediated drug resistance: An emerging concept in cancer therapy Clin Cancer Res 7 2001 2168 2181
110. Y. Shi, J.S. Lee, and K.M. Galvin Everything you have ever wanted to know about Yin Yang 1 Biochim Biophys Acta 1332 1997 F49 F66
111. Y. Shi, E. Seto, L.S. Chang, and T. Shenk Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein Cell 67 1991 377 388
112. E. Shin, K.B. Lee, S.Y. Park, S.H. Kim, H.S. Ryu, and Y.N. Park Gene expression profiling of human hepatoblastoma using archived formalinfixed and paraffin-embedded tissues Virchows Arch 458 2011 453 465
113. J.A. Simon, and C.A. Lange Roles of the EZH2 histone methyltransferase in cancer epigenetics Mutat Res 647 2008 21 29
114. K.V. Sitwala, K. Adams, and D.M. Markovitz YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter Oncogene 21 2002 8862 8870
115. T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J.S. Marron, and A. Nobel Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci U S A 100 2003 8418 8423
116. D. Spentzos, D.A. Levine, M.F. Ramoni, M. Joseph, X. Gu, and J. Boyd Gene expression signature with independent prognostic significance in epithelial ovarian cancer J Clin Oncol 22 2004 4700 4710
117. G. Sui The regulation of YY1 in tumorigenesis and its targeting potential in cancer therapy Mol Cell Pharmacol 1 2009 157 176
118. G. Sui, B. Affar el, Y. Shi, C. Brignone, N.R. Wall, and P. Yin Yin Yang 1 is a negative regulator of p53 Cell 117 2004 859 872
119. L. Sun, A.M. Hui, Q. Su, A. Vortmeyer, Y. Kotliarov, and S. Pastorino Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain Cancer Cell 9 2006 287 300
120. C. Sun, C. Song, Z. Ma, K. Xu, Y. Zhang, and H. Jin Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsy Proteome Sci 9 2011 22
121. D.S. Tan, M. Gerlinger, B.T. Teh, and C. Swanton Anti-cancer drug resistance: Understanding the mechanisms through the use of integrative genomics and functional RNA interference Eur J Cancer 46 2010 2143 2144
122. S. Tang, M. Mishra, D.P. Frazier, M.L. Moore, K. Inoue, and R. Deora Positive and negative regulation of prostate stem cell antigen expression by Yin Yang 1 in prostate epithelial cell lines PLoS One 7 2012 e35570
123. B.S. Taylor, N. Schultz, H. Hieronymus, A. Gopalan, Y. Xiao, and B.S. Carver Integrative genomic profiling of human prostate cancer Cancer Cell 18 2010 11 22
124. TCGA data: "The results shown here are in whole or part based upon data generated by the TCGA Research Network http://cancergenome.nih.gov/ 2014
125. B.L. Thériault, H.D. Basavarajappa, H. Lim, S. Pajovic, B.L. Gallie, and T.W. Corson Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer PLoS One 9 2014 e91540
126. M.J. Thomas, and E. Seto Unlocking the mechanisms of transcription factor YY1: Are chromatin modifying enzymes the key? Gene 236 1999 197 208
127. M. Thomassen, Q. Tan, and T.A. Kruse Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer BMC Cancer 8 2008 394
128. P.J. Valk, R.G. Verhaak, M.A. Beijen, C.A. Erpelinck, Barjesteh van Waalwijk, and S. van Doorn-Khosrovani Prognostically useful gene-expression profiles in acute myeloid leukemia N Engl J Med 350 2004 1617 1628
129. S. Varambally, S.M. Dhanasekaran, M. Zhou, T.R. Barrette, C. Kumar-Sinha, and M.G. Sanda The polycomb group protein EZH2 is involved in progression of prostate cancer Nature 419 2002 624 629
130. M.I. Vega, A.R. Jazirehi, S. Huerta-Yepez, and B. Bonavida Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: Role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively J Immunol 175 2005 2174 2183
131. M. Wan, W. Huang, T.E. Kute, L.D. Miller, Q. Zhang, and H. Hatcher Yin Yang 1 Plays an Essential Role in Breast Cancer and Negatively Regulates p27 Am J Pathol 180 2012 2120 2133
132. H. Wang, E. Hertlein, N. Bakkar, H. Sun, S. Acharyya, and J. Wang NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes Mol Cell Biol 27 2007 4374 4387
133. W. Weng, M. Wang, S. Xie, Y. Long, F. Li, and F. Sun YY1-C/EBPα-miR34a regulatory circuitry is involved in renal cell carcinoma progression Oncol Rep 31 2014 1921 1927
134. F.H. Wilkinson, K. Park, and M.L. Atchison Polycomb recruitment to DNA in vivo by the YY1 REPO domain Proc Natl Acad Sci U S A 103 2006 19296 19301
135. W. Xu, S. Banerji, J.R. Davie, F. Kassie, D. Yee, and R. Kratzke Yin Yang gene expression ratio signature for lung cancer prognosis PLoS One 8 2013 e68742
136. W.M. Yang, C. Inouye, Y. Zeng, D. Bearss, and E. Seto Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3 Proc Natl Acad Sci U S A 93 1996 12845 12850
137. Y. Yang, L. Zhou, L. Lu, L. Wang, X. Li, and P. Jiang A novel miR-193a-5p-YY1-APC regulatory axis in human endometrioid endometrial adenocarcinoma Oncogene 32 2013 3432 3442
138. Y.L. Yao, W.M. Yang, and E. Seto Regulation of transcription factor YY1 by acetylation and deacetylation Mol Cell Biol 21 2001 5979 5991
139. A. Zaravinos, G.I. Lambrou, I. Boulalas, D. Delakas, and D.A. Spandidos Identification of common differentially expressed genes in urinary bladder cancer PLoS One 6 2011 e18135
140. A. Zaravinos, and D.A. Spandidos Yin yang 1 expression in human tumors Cell Cycle 9 2010 512 522
141. S. Zhang, T. Jiang, L. Feng, J. Sun, H. Lu, and Q. Wang Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha J Mol Med 90 2012 1069 1077
142. N. Zhang, X. Li, C.W. Wu, Y. Dong, M. Cai, and M.T. Mok microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis Oncogene 32 2013 5078 5088
143. Q. Zhang, D.B. Stovall, K. Inoue, and G. Sui The oncogenic role of Yin Yang 1 Crit Rev Oncog 16 2011 163 197
144. J.J. Zhang, Y. Zhu, K.L. Xie, Y.P. Peng, J.Q. Tao, and J. Tang Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism Mol Cancer 13 2014 130
145. H. Zheng, J. Chu, Y. Zeng, H.H. Loh, and P.Y. Law Yin Yang 1 phosphorylation contributes to the differential effects of mu-opioid receptor agonists on microRNA-190 expression J Biol Chem 285 2010 21994 22002